A clinical trial showed an immediate, fast, rapid-acting, sustained response to 25 milligrams (of COMP360) of the anti-depressant drug COMP360 for treatment-resistant depression. Results of the study, published Wednesday in The New England Journal of Medicine, found that a small group of people in all three doses experienced suicidal thoughts or injuries over a 12-week…